Overview
Metastatic adenocarcinoma to the urinary bladder is a rare condition where cancer originating from another site, specifically adenocarcinoma, has spread to the bladder. This diagnosis implies a primary cancer elsewhere in the body has metastasized.Diagnosis
No information on diagnosis is available in the provided abstracts.Management
Intravesical instillation of hyaluronic acid (HA) with or without chondroitin sulphate (ChS) may improve pain, voiding symptoms, and irritative symptoms in bladder conditions 1.
This treatment may also reduce the risk of recurrent urinary tract infections (rUTI) compared to standard care 1.
Randomized controlled trials suggest that the combined use of HA/ChS may lead to better outcomes and lower infection rates compared to placebo or standard of care 1.
Improvement in sexual function and quality of life has also been observed with HA/ChS treatment 1.Special Populations
No information on special populations is available in the provided abstracts.Key Recommendations
Intravesical instillation of hyaluronic acid (HA) with or without chondroitin sulphate (ChS) can significantly improve pain, voiding, and irritative symptoms in chronic bladder diseases 1. (Evidence: Strong)
The combined use of HA/ChS may result in better outcomes and a lower infection rate compared to placebo or standard of care 1. (Evidence: Strong)
Intravesical HA/ChS treatment may reduce the risk of recurrent urinary tract infections (rUTI) when compared to standard care 1. (Evidence: Moderate)References
1 Corona G, Capogrosso P, Baldini S, Rastrelli G, Vignozzi L, Romero-Otero J et al.. Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta-analysis. BJU international 2026. link